- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/07 - Bacillus
Patent holdings for IPC class A61K 39/07
Total number of patents in this class: 289
10-year publication summary
|
20
|
25
|
24
|
16
|
14
|
15
|
12
|
11
|
15
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20059 |
10 |
| Bayer Cropscience LP | 364 |
7 |
| The Regents of the University of Michigan | 4739 |
7 |
| Altimmune Inc | 25 |
7 |
| Spogen Biotech Inc. | 137 |
7 |
| The Trustees of the University of Pennsylvania | 4337 |
5 |
| Horizon Technology Finance Corporation | 24 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
5 |
| Himv LLC | 29 |
5 |
| President and Fellows of Harvard College | 5995 |
4 |
| The Johns Hopkins University | 5709 |
3 |
| Dynavax Technologies Corporation | 117 |
3 |
| Emergent BioSolutions Inc. | 35 |
3 |
| Ganeden Biotech, Inc. | 55 |
3 |
| Molecular Express, Inc. | 13 |
3 |
| PharmAthene, Inc. | 10 |
3 |
| Phico Therapeutics Ltd. | 23 |
3 |
| Soligenix, Inc. | 51 |
3 |
| The Texas a & M University System | 1725 |
3 |
| Texas Tech University System | 588 |
3 |
| Other owners | 197 |